**New rifamycin derivatives**

Rifalazil, a semisynthetic RIF, is described by a long half-life and is more effective than RIF and rifabutin against *Mtb* strains [64]. However, high-intensity RIF– resistant strains present cross-resistance to all rifamycin drugs [65].
